These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8059554)

  • 1. Tuberculosis prophylaxis in HIV infection.
    Trevett A; Temu P; Naraqi S
    P N G Med J; 1993 Sep; 36(3):256. PubMed ID: 8059554
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis and HIV infection.
    Bevilacqua N; Marasca G; Moscati A; Fantoni M; Ricci F; Ortona L
    Lancet; 1993 Sep; 342(8872):677. PubMed ID: 8103158
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
    Aguado JM; Pulido F; Moreno S
    N Engl J Med; 1997 Dec; 337(23):1696-7; author reply 1697. PubMed ID: 9411240
    [No Abstract]   [Full Text] [Related]  

  • 4. Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
    Dore GJ; Law MG; Kaldor JM
    N Engl J Med; 1997 Dec; 337(23):1697. PubMed ID: 9411241
    [No Abstract]   [Full Text] [Related]  

  • 5. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
    Fitzgerald DW; Morse MM; Pape JW; Johnson WD
    Clin Infect Dis; 2000 Dec; 31(6):1495-7. PubMed ID: 11096020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis and mycobacterioses--current problems].
    Milchev M
    Vutr Boles; 1999; 31(1):5-8, 11. PubMed ID: 10847142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection.
    Pape JW; Jean SS; Ho JL; Hafner A; Johnson WD
    Lancet; 1993 Jul; 342(8866):268-72. PubMed ID: 8101302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
    Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
    Turner MT
    N Engl J Med; 1998 Mar; 338(12):841-2. PubMed ID: 9508640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tuberculosis and HIV infection].
    Rieder HL
    Pneumologie; 1994 Feb; 48(2):144-50. PubMed ID: 8183866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis in the AIDS era.
    Ellenbogen C
    N C Med J; 1993 Jan; 54(1):9-14. PubMed ID: 8426665
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between HIV and tuberculosis: technical guide.
    Bull Pan Am Health Organ; 1993; 27(3):297-310. PubMed ID: 8220525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
    Desvarieux M
    N Engl J Med; 1998 Mar; 338(12):841; author reply 842-3. PubMed ID: 9508639
    [No Abstract]   [Full Text] [Related]  

  • 15. Opportunistic infections in AIDS patients. Current management and prevention.
    Hughes WT
    Postgrad Med; 1994 Jan; 95(1):81-2, 85-8, 93. PubMed ID: 8278302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid chemoprophylaxis for dual HIV-TB infection: a cautionary tale.
    FitzGerald JM
    Can Commun Dis Rep; 1995 Feb; 21(4):29-32; discussion 32, 35. PubMed ID: 7735192
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemiological review of tuberculosis in the Puerto Rican population.
    Pérez-Perdomo R; Pérez-Cardona CM
    P R Health Sci J; 1999 Jun; 18(2):117-22. PubMed ID: 10461317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid TB prophylaxis effective in drug users with HIV.
    J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.